Topic: chronic inflammation
The financing will support clinical testing of PD-L1x4-1BBxHSA trispecific ND021 in cancer patients.
Nodthera raised £28 million in series A funding to develop NLRP3 inflammasome inhibitors for chronic inflammation.
SetPoint Medical rounded up $30 million, which will bankroll a phase 2 trial of its bioelelectronic therapy for rheumatoid arthritis.
The VC wing of Novartis has joined with Fountain Healthcare Partners to lead a $17 million round in Inflazome, a chronic inflammatory disease startup.
Bioelectronics player Endonovo has enacted a binding letter of intent to acquire Rio Grande Neuroscience.